The FDA has expanded the approval of Lumryz (sodium oxybate) extended-release oral suspension to include treatment of pediatric narcolepsy.

Disease-modifying therapy (DMT) use for multiple sclerosis (MS) in pregnancy is associated with certain adverse outcomes.

For men, high levels of physical activity and fitness are associated with reduced risk of amyotrophic lateral sclerosis (ALS).

Vagus nerve stimulation shows a positive treatment effect and improved quality of life among patients with treatment-resistant depression.

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Health status, mental health, and health inequities worsened in the United States from 2014 to 2022 among transgender (TGD) adults.

Women in the health care workforce are more likely to experience verbal abuse, sexual harassment, and bullying, while men are more likely to experience physical violence.

An expert panel has developed a hospital care plan for Parkinson disease to avoid preventable harm among patients.

In an article published online Dec. 3 in European Radiology, the authors explore the performance and optimal combination of MRI.

Patients with iRBD showed decreased GMV in the prefrontal cortices, temporal lobe, and caudate, and increased cerebellar and thalamic GMV.

The use of short-term hormone therapy for menopause is not associated with long-term cognitive impact after 10 years.

Older adults with major depressive disorder (MDD) demonstrate distinct and riskier driving behaviors than those without MDD.